N-acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: A meta-analysis of eight randomized controlled trials

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Gu, Wan Jie ^a   Wu, Zhen Jie ^b   Wang, Peng Fei ^c   Htet Aung, Lynn H ^a   Yin, Rui Xing ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; SCAVENGER;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIXED EFFECT MODEL; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LENGTH OF STAY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE ATRIAL FIBRILLATION; POSTOPERATIVE PERIOD; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANLDOM EFFECT MODEL; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; AGED; HEART SURGERY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857247553     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-10     Document Type: Article

References (33)

1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk for atrial fibrillation after cardiac surgery. JAMA 2004, 291. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group):1720-1729.
2. Fuster V, Ryden LE. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and Policy Conference. American Heart Association. 2002 Heart and Stroke Statistical Update 2001, Dallas, Texas: American Heart Association, (accessed 8/7/02).
3. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997, 336:1429-1434. 10.1056/NEJM199705153362006, 9145681.
4. Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P, Cantore C, Biglioli P, Sala A. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 2008, 118:1612e-18.
5. Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart 2011, 97:1636-1642. 10.1136/heartjnl-2011-300245, 21865202.
6. Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy 2010, 30(749):274e-318e.
7. Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg 2010, 5:121. 10.1186/1749-8090-5-121, 3006380, 21118555.
8. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011, 57:e101-e198.
9. Ho KM, Lewis JP. Prevention of atrial fibrillation in cardiac surgery: time to consider a multimodality pharmacological approach. Cardiovasc Ther 2010, 28:59-65. 10.1111/j.1755-5922.2009.00117.x, 20074260.
10. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007, 115:135-143. 10.1016/j.ijcard.2006.04.026, 16764958.
11. Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009, 72:466-467. 10.1016/j.mehy.2008.08.031, 19103473.
12. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, Ibrisim E. N-acetylcysteine for theprevention of postoperative atrial fibrillation: A prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008, 29:625-631. 10.1093/eurheartj/ehn011, 18263874.
13. Eren N, Cakir O, Oruc A, Kaya Z, Erdinc L. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 2003, 18:345-350. 10.1191/0267659103pf696oa, 14714769.
14. Orhan G, Yapici N, Yuksel M, Sargin M, Şenay S, Yalçin AS, Aykaç Z, Aka SA. Effects of N-acetylcysteineon myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels 2006, 21:42-47. 10.1007/s00380-005-0873-1, 16440148.
15. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007, 133:7-12. 10.1016/j.jtcvs.2006.05.070, 17198774.
16. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, Matalanis G, Buxton B, Doolan L, Bellomo R. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007, 35:1324-1331. 10.1097/01.CCM.0000261887.69976.12, 17414730.
17. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with preexisting moderate renal insufficiency. Can J Anaesth 2007, 54:872-881. 10.1007/BF03026790, 17975231.
18. Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R, Ibrisim E. Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. J Cardiovasc Surg (Torino) 2008, 49:527-531.
19. Kim JC, Hong SW, Shim JK, Yoo KJ, Chun DH, Kwak YL. Effect of N-acetylcystein on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. Acta Anaesthesiol Scand 2011, 55:452-459. 10.1111/j.1399-6576.2011.02407.x, 21391924.
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
21. Sutton AJ, Abrams KR, Jones DR. Methods for Meta-analysis in Medical Research 2000, Chichester: Wiley.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
23. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
25. Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004, 62:105-111. 10.1016/j.cardiores.2004.01.018, 15023557.
26. Ozaydin M, Dogan A, Varol E, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007, 107:117-121. 10.1159/000094589, 16864965.
27. Dilaveris P, Giannopoulos G, Synetos A, Stefanadis C. The role of renin angiotensin systemblockade in the treatment of atrial fibrillation. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:387-403. 10.2174/156800605774370317, 16248831.
28. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 2006, 27:136-149.
29. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR. Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007, 282:28063-28073. 10.1074/jbc.M704893200, 17656369.
30. Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA. Oral vitamin Cadministration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 2005, 102:321-326. 10.1016/j.ijcard.2004.12.041, 15982504.
31. Goettea A, Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 2004, 102:17-36. 10.1016/j.pharmthera.2004.01.001, 15056496.
32. van der Harst P, Volbeda M, Voors AA, Buikema H, Wassmann S, Bohm M, Nickenig G, van Gilst WH. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension 2004, 44:930-934. 10.1161/01.HYP.0000147823.50497.a9, 15505113.
33. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996, 94:390-397.